HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

• J0576

  Injection, buprenorphine extended-release (brixadi), 1 mg   Discontinued

• J0577

  Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy   New

• J0578

  Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy   New

• J0583

  Injection, bivalirudin, 1 mg

• J0584

  Injection, burosumab-twza 1 mg

• J0585

  Injection, onabotulinumtoxina, 1 unit

• J0586

  Injection, abobotulinumtoxina, 5 units

• J0587

  Injection, rimabotulinumtoxinb, 100 units

• J0588

  Injection, incobotulinumtoxin a, 1 unit

• J0589

  Injection, daxibotulinumtoxina-lanm, 1 unit   New

• ---

  ---

  Continued

• J0591

  Injection, deoxycholic acid, 1 mg

• J0592

  Injection, buprenorphine hydrochloride, 0.1 mg

• J0593

  Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)

• J0594

  injection, busulfan, 1 mg

• J0595

  Injection, butorphanol tartrate, 1 mg

• J0596

  Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units

• J0597

  Injection, c-1 esterase inhibitor (human), berinert, 10 units

• J0598

  Injection, c-1 esterase inhibitor (human), cinryze, 10 units

• J0599

  Injection, c-1 esterase inhibitor (human), (haegarda), 10 units

• J0600

  Injection, edetate calcium disodium, up to 1000 mg

• J0604

  Cinacalcet, oral, 1 mg, (for esrd on dialysis)

• J0606

  Injection, etelcalcetide, 0.1 mg

• J0610

  Injection, calcium gluconate (fresenius kabi), per 10 ml

• J0611

  Injection, calcium gluconate (wg critical care), per 10 ml

• J0612

  Injection, calcium gluconate, not otherwise specified, 10 mg

• J0613

  Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg

• J0620

  Injection, calcium glycerophosphate and calcium lactate, per 10 ml

• J0630

  Injection, calcitonin salmon, up to 400 units

• J0636

  Injection, calcitriol, 0.1 mcg

• J0637

  Injection, caspofungin acetate, 5 mg

• ---

  ---

  Continued

• J0638

  Injection, canakinumab, 1 mg

• J0640

  Injection, leucovorin calcium, per 50 mg

• J0641

  Injection, levoleucovorin, not otherwise specified, 0.5 mg

• J0642

  Injection, levoleucovorin (khapzory), 0.5 mg

• J0650

  Injection, levothyroxine sodium, not otherwise specified, 10 mcg   New

• J0651

  Injection, levothyroxine sodium (fresenius kabi) not therapeutically equivalent to j0650, 10 mcg   New

• J0652

  Injection, levothyroxine sodium (hikma) not therapeutically equivalent to j0650, 10 mcg   New

• J0665

  Injection, bupivicaine, not otherwise specified, 0.5 mg

• J0670

  Injection, mepivacaine hydrochloride, per 10 ml

• J0688

  Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg

• J0689

  Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg

• J0690

  Injection, cefazolin sodium, 500 mg

• J0691

  Injection, lefamulin, 1 mg

• J0692

  Injection, cefepime hydrochloride, 500 mg

• J0693

  Injection, cefiderocol, 5 mg

• J0694

  Injection, cefoxitin sodium, 1 gm

• J0695

  Injection, ceftolozane 50 mg and tazobactam 25 mg

• J0696

  Injection, ceftriaxone sodium, per 250 mg

• J0697

  Injection, sterile cefuroxime sodium, per 750 mg

• J0698

  Injection, cefotaxime sodium, per gm